Novo Nordisk A/S
Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark. Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulin franchise, including modern insulins, human insulins, insulin-related sales, and oral antidiabetic drugs, as well as GLP-1 compounds in development for both the treatment of type 2 diabetes and as an anti-obesity agent. The Biopharmaceuticals segment provides products in the areas of haemostasis management, growth hormone therapy, hormone replacement therapy, inflammation therapy, and other therapy areas. The company sells its products principally in the United States, Japan, China, the Russian Federation, India, Turkey, and other European countries.
Contact Details
Office Address
Novo Nordisk A/S
Novo Alle
Bagsvaerd, Denmark 2880
Phone: +45-44-44-88-88
Fax: +45-44-49-05-55
Executives
Chief Exec. Officer and Pres.
Mr. Lars Rebien Sorensen
Chief Financial Officer
Mr. Jesper Brandgaard
.webp)
.webp)
.webp)
.webp)
.webp)
